Detalhe da pesquisa
1.
Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma.
N Engl J Med
; 389(2): 148-157, 2023 Jul 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37272527
2.
Axicabtagene ciloleucel versus standard of care in second-line large B-cell lymphoma: outcomes by metabolic tumor volume.
Blood
; 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38557775
3.
Real-World and Clinical Trial Outcomes in Large B-cell Lymphoma with Axicabtagene Ciloleucel Across Race and Ethnicity.
Blood
; 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38635762
4.
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma.
N Engl J Med
; 386(7): 640-654, 2022 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34891224
5.
How I treat cytopenias after CAR T-cell therapy.
Blood
; 141(20): 2460-2469, 2023 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36800563
6.
Five-year follow-up of ZUMA-1 supports the curative potential of axicabtagene ciloleucel in refractory large B-cell lymphoma.
Blood
; 141(19): 2307-2315, 2023 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36821768
7.
Whole-genome sequencing reveals complex genomic features underlying anti-CD19 CAR T-cell treatment failures in lymphoma.
Blood
; 140(5): 491-503, 2022 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35476848
8.
Autologous transplant vs chimeric antigen receptor T-cell therapy for relapsed DLBCL in partial remission.
Blood
; 139(9): 1330-1339, 2022 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34570879
9.
Benefit of axicabtagene ciloleucel versus chemoimmunotherapy in older patients and/or patients with poor ECOG performance status with relapsed or refractory large B-cell lymphoma after 2 or more lines of prior therapy.
Am J Hematol
; 99(5): 880-889, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38504387
10.
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma.
N Engl J Med
; 382(14): 1331-1342, 2020 04 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32242358
11.
Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma.
Blood
; 137(19): 2621-2633, 2021 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33512407
12.
CAR-HEMATOTOX: a model for CAR T-cell-related hematologic toxicity in relapsed/refractory large B-cell lymphoma.
Blood
; 138(24): 2499-2513, 2021 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34166502
13.
Allogeneic transplant following CAR T-cell therapy for large B-cell lymphoma.
Haematologica
; 108(1): 98-109, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35833303
14.
The CAR-HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL.
Am J Hematol
; 98(11): 1699-1710, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37584447
15.
A multicenter phase 1 study of nivolumab for relapsed hematologic malignancies after allogeneic transplantation.
Blood
; 135(24): 2182-2191, 2020 06 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32478814
16.
Axicabtagene Ciloleucel in Large B-Cell Lymphoma. Reply.
N Engl J Med
; 389(12): 1152-1153, 2023 Sep 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37733323
17.
The roles of T cell competition and stochastic extinction events in chimeric antigen receptor T cell therapy.
Proc Biol Sci
; 288(1947): 20210229, 2021 03 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-33757357
18.
Immune reconstitution and associated infections following axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma.
Haematologica
; 106(4): 978-986, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32327504
19.
Quality of life in caregivers of patients receiving chimeric antigen receptor T-cell therapy.
Psychooncology
; 30(8): 1294-1301, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33739548
20.
Efficacy and safety of CD19-directed CAR-T cell therapies in patients with relapsed/refractory aggressive B-cell lymphomas: Observations from the JULIET, ZUMA-1, and TRANSCEND trials.
Am J Hematol
; 96(10): 1295-1312, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34310745